KCM
Kingdon Capital Management’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Buy |
684,707
+194,707
| +40% | +$1.08M | 0.51% | 46 |
|
|
2025
Q1 | $2.11M | Buy |
490,000
+43,000
| +10% | +$185K | 0.22% | 51 |
|
|
2024
Q4 | $9.56M | Sell |
447,000
-50,000
| -10% | -$1.07M | 1.36% | 29 |
|
|
2024
Q3 | $9.35M | Hold |
497,000
| – | – | 1.04% | 38 |
|
|
2024
Q2 | $11.3M | Hold |
497,000
| – | – | 1.21% | 23 |
|
|
2024
Q1 | $14.6M | Sell |
497,000
-3,043,000
| -86% | -$89.3M | 1.59% | 15 |
|
|
2023
Q4 | $2.79M | Buy |
3,540,000
+500,000
| +16% | +$395K | 0.35% | 48 |
|
|
2023
Q3 | $2.13M | Hold |
3,040,000
| – | – | 0.25% | 50 |
|
|
2023
Q2 | $4.16M | Hold |
3,040,000
| – | – | 0.39% | 45 |
|
|
2023
Q1 | $5.5M | Buy |
3,040,000
+2,500,000
| +463% | +$4.53M | 1.03% | 33 |
|
|
2022
Q4 | $261K | Hold |
540,000
| – | – | 0.05% | 37 |
|
|
2022
Q3 | $426K | Hold |
540,000
| – | – | 0.05% | 43 |
|
|
2022
Q2 | $1.04M | Hold |
540,000
| – | – | 0.18% | 51 |
|
|
2022
Q1 | $1.92M | Hold |
540,000
| – | – | 0.2% | 58 |
|
|
2021
Q4 | $4.24M | Buy |
+540,000
| New | +$4.24M | 0.49% | 43 |
|